About Us Blogs
  • About Us
  • Blogs

Therapy

A collection of 5 posts
Sweden’s Meela Secures €2.6 Million to Revolutionize Mental Health Matchmaking
Medlr

Sweden’s Meela Secures €2.6 Million to Revolutionize Mental Health Matchmaking

Meela, a Swedish mental health platform, raised €2.6M in seed funding to enhance its research-based matchmaking for psychologists and therapy methods.
Jul 5, 2024 2 min read
Roche Introduces Ocrevus, Groundbreaking Therapy for Multiple Sclerosis in India
News

Roche Introduces Ocrevus, Groundbreaking Therapy for Multiple Sclerosis in India

Roche Pharma India unveils Ocrevus, a first-in-class treatment for both relapsing and primary progressive forms of multiple sclerosis (MS).
Mar 5, 2024 2 min read
Study Explores Long-Term Side Effects of Prostate Cancer Treatments
News

Study Explores Long-Term Side Effects of Prostate Cancer Treatments

A new study sheds light on the long-term side effects of various treatments for prostate cancer, a common cancer often carrying a favorable prognosis.
Feb 9, 2024 2 min read
Breast Cancer Cells Tap Into Surroundings for Energy During Starvation, Unveiling Promising Therapeutic Target
News

Breast Cancer Cells Tap Into Surroundings for Energy During Starvation, Unveiling Promising Therapeutic Target

Scientists at the University of Sheffield have uncovered a unique survival mechanism in breast cancer cells, where they consume their surroundings during nutrient scarcity within tumors.
Jan 19, 2024 2 min read
Cancer DNA Detection By Modified Bacteria in Tumors
News Featured

Cancer DNA Detection By Modified Bacteria in Tumors

The frontier of cancer detection is being reshaped by the ingenious use of modified bacteria within tumor sites.
Aug 16, 2023 2 min read
Page 1 of 1
At Medlr, we value our users and strive to provide the best possible experience. If you have any questions, comments, or feedback, please don't hesitate to contact us. You can reach us at the following:
Company
About Us Blogs FAQs Contact Us
Policy Info
Privacy Policy Terms And Conditions Editorial Policy
Get Our App
Get Our App
Subscribe to our Newsletter